Accelerated demand for San Diego’s class A and B office inventory has had an effect on on vacancy rates coming into 2022. Expansion from local biotech firms absorbing vacant space with larger transactions requiring new construction are driving demand throughout Torrey Pines, Carmel Valley and Del Mar Heights.

Breakthrough Properties and Gemdale are building large lab campuses along the State Route 56 corridor that received pre-lease commitments totaling 850,000 square feet since the end of last year. BD Biosciences signed for 220,000 square feet at Torrey View and Neurocrine Biosciences leased roughly 630,000 square feet at Aperture Del Mar.

Alexandria Real Estate Equities pre-leased 430,000 square feet to Brisol Myers Squibb at the interchange of I-5 and I-805 at its Campus Point 4 building in Alexandria Point, where Amazon occupies more than 130,000 square feet.

Those large deals at upscale office properties have driven leasing during the first quarter in San Diego market to the highest quarterly total in more than 15 years, with over 2.5 million square feet of new leasing activity.

In turn, there has been a noticeable shift in where that activity is falling.

Historically, leasing in urban locations in San Diego have led volume. However, since 2019, demand has shifted to suburban areas of San Diego, where many firms are choosing to locate near where their workers live. The pandemic work-from-home and subsequent ‘hub and spoke’ model adopted by larger businesses to accommodate suburban employee bases continues to keep vacancy low in suburban submarkets north of Hwy-52.

Companies forecasting their office space needs for the next 12 - 24 months should expect rates to increase in suburban markets, and inventory to remain low. However, there are hidden opportunities to reduce occupancy cost in the urban markets, specifically downtown San Diego, where the sublease inventory is still high and large blocks of space sit vacant for longer.